Small Intestinal Bacterial Overgrowth: A Review of Current Antibiotic Strategies and Emerging Alternatives

Read full text Summarise with VIRAT
Authors: Deepjyoti Chetia, Sampurna Borbora
Cited by: 0
References: 45

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Small intestinal bacterial overgrowth, a common gastrointestinal condition, remains largely undiagnosed. The treatment of choice is antibiotic therapy, with rifaximin being the most popular. Studies show a high recurrence rate after initial treatment, indicating the necessity for alternative treatment options. This narrative review provides a general description of the condition with the associated pathophysiology, clinical presentation, diagnosis, imaging, the role of older antibiotics, and contemporary interventions. Furthermore, it emphasizes the evidence of emerging treatments such as herbal medicine, probiotics, faecal microbiota transplantation (FMT), and other dietary modifications. It also emphasizes novel strategies, such as engineered probiotics and phage therapy.

Fields of Study & Subjects

Gastrointestinal motility and disorders Gut microbiota and health Probiotics and Fermented Foods

Publication details

Journal / source
Journal of Datta Meghe Institute of Medical Sciences University
Volume
21
Issue
1
Pages
4–10
Publication date
1 January 2026
Language
EN